Future Outlook of the Cell And Gene Therapy Supply Chain/Logistics Market: Growth, Trends, and Emerging Opportunities Explored
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the cell and gene therapy supply chain/logistics market grown in recent years?
The market size for the cell and gene therapy supply chain/logistics has seen swift expansion in the past few years. It is projected to escalate from $1.41 billion in 2024 to $1.58 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 11.8%. Key reasons for such significant growth during the historic period include an increased incidence of chronic diseases, more effective management of supply chain requirements, greater attention to maintaining drug integrity, more sophisticated regulatory frameworks, and a heightened focus on risk reduction and compliance.
How is the cell and gene therapy supply chain/logistics market size expected to evolve during the forecast period?
Over the coming years, a sharp increase in the size of the cell and gene therapy supply chain/logistics market is anticipated. It’s projected to reach a valuation of $2.44 billion in 2029, following a Compound Annual Growth Rate (CAGR) of 11.5%. This predicted development over the forecast period is due to the expansion of personalized medicine, the creation of cell-free therapies, a rising occurrence of chronic diseases, the global cell therapy manufacturing market’s growth, and effective supply chain requirement utilization. The forecast period will be characterized by major trends including amplified research and development spending, the embrace of groundbreaking technologies, beneficial initiatives and programs for better access, as well as partnerships and collaborations among cell and gene therapy companies, supply chain providers and logistics companies, alongside the provision of adjustable services that cater to any stage of patient identification.
Get your cell and gene therapy supply chain/logistics market report here!
Which key drivers are propelling the cell and gene therapy supply chain/logistics market’s growth?
The escalating demand for cell and gene therapies is propelling growth in the market for cell and gene therapy supply chain and logistics. These cutting-edge medical procedures, which transform cells or genes to combat diseases, are presenting potential progress against conditions that have hitherto been incurable. It’s necessary that these groundbreaking cell and gene therapies be stored under suitable temperature and conditions. That’s where supply chain and logistics services come into play, providing aid from sourcing to distribution and safekeeping of these cell and gene therapies. To illustrate, the American Society of Gene & Cell Therapy, a non-profit medical and scientific society based in the U.S., reported a 10% increase in Phase III clinical trials for gene therapies in Q3 2023 – the first such uptick since Q3 2022. Consequently, the rising demand for cell and gene therapies is pushing the cell and gene therapy supply chain and logistics market ahead.
What are the market segments in the cell and gene therapy supply chain/logistics industry?
The cell and gene therapy supply chain/logistics market covered in this report is segmented –
1) By Type Of Software Solution: Cell Orchestration Platform, Enterprise Manufacturing System, Inventory Management System, Laboratory Information Management System, Logistics Management System, Patient Management System, Quality Management System, Tracking And Tracing System
2) By Mode Of Deployment: Cloud-Based Solution, On-Premises Solution
3) By Component: Cryogenic Shippers, Cryogenic Storage Freezers, Ultra-Low Freezers, Cold Chain Management Systems, Shipment, Storage Medium, Cryogenic Packout Kits, Other Components
4) By Application Area: Donor Eligibility Assessment, Sample Collection, Manufacturing, Logistics, Patient Verification, Treatment Follow-Up
5) By End User: Biobank, Cell Therapy Lab, Hospital, Research Institute, Commercial Organization
Subsegments:
1) By Cell Orchestration Platform: Workflow Management, Scheduling And Coordination Tools
2) By Enterprise Manufacturing System: Production Planning And Control, Manufacturing Execution Systems (MES)
3) By Inventory Management System: Stock Tracking And Management, Inventory Forecasting And Optimization
4) By Laboratory Information Management System (LIMS): Sample Tracking And Management, Data Management And Reporting
5) By Logistics Management System: Route Optimization And Planning, Transportation Management
6) By Patient Management System: Patient Scheduling And Coordination, Data Management And Tracking Of Patient Outcomes
7) By Quality Management System: Compliance Tracking, Quality Assurance And Control
8) By Tracking And Tracing System: Real-Time Tracking Of Shipments, Chain Of Custody Documentation
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12631&type=smp
Which leading companies are shaping the growth of the cell and gene therapy supply chain/logistics market?
Major companies operating in the cell and gene therapy supply chain/logistics market include AmerisourceBergen Corporation, United Parcel Service, Thermo Fisher Scientific Inc., Avantor Sciences, Lonza Group AG, Arvato Group, Catalent Inc., Charles River Laboratories International, Parexel International Corporation, Cytiva, Almac Group, World Courier, Sharp Packaging Services, PCI Pharma Services, Cryoport Inc., Brooks Life Sciences, BioLife Solutions Inc., Biocair Inc., QuickSTAT, Clarkston Consulting Inc., Central Pharma, TrakCel limited, MAK-SYSTEM International Group, Hypertrust Patient Data Care GmbH, Atelerix Ltd., Polar Express Transportation, Be The Match BioTherapies Inc., Yourway Biopharma Services Company, Azenta Life Sciences Inc., Biostor Ltd.
What key trends are currently impacting the cell and gene therapy supply chain/logistics market’s development?
The rise of advanced technology platforms is a significant trend gaining traction in the cell and gene therapy supply chain/logistics market. Leading firms in the marketplace are creating cutting-edge tech platforms for cell and gene therapies to maintain their market standing. For example, in April 2023, the Cell and Gene Therapy (CGT) Integration Hub was launched by AmerisourceBergen Corporation, a US healthcare company renowned for its expertise in cell and gene therapy supply chain logistics. The CGT Integration Hub owes its functionality to AmerisourceBergen’s inventive customer relationship management (CRM) system. It has the ability to be integrated with the biopharma platform, improving the supervision of the progress and delivery of cell and gene therapies.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12631
Which geographic areas are influencing the growth of the cell and gene therapy supply chain/logistics market?
North America was the largest region in the cell and gene therapy supply chain/logistics market in 2024. The regions covered in the cell and gene therapy supply chain/logistics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Cell Based Assays Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report
Healthcare Supply Chain Management Global Market Report 2024
Nucleic Acid Based Gene Therapy Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
